Clin2
NCT07121751Possibly a fitNot yet recruiting

Better egg stimulation for women with low egg count

Hypo-responderInfertility (IVF Patients)OVARIAN STIMULATION

Part of Women’s health & pregnancy clinical trials.

This study tests a different type of fertility medication to help women who had fewer than 9 eggs retrieved in a previous IVF cycle. It's designed for women between 18 and 40 with a specific hormone profile, and aims to improve egg collection results.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
150 people
Ages
18 years to 40 years
Study type
Interventional

Who can take part

  • You are between 18 and 40 years old
  • You have had fewer than 9 eggs retrieved in a previous IVF or ICSI cycle
  • You have a normal hormone level (AMH ≥1.2 ng/ml) and/or a certain number of fluid-filled sacs (AFC ≥5) on your ovaries
  • Your previous IVF cycle used a low dose of stimulation medication (≤225 IU of FSH or a mix of rFSH and hMG)
  • You have regular periods (every 24 to 35 days)
  • You have a healthy uterus and your partner or donor has motile sperm if using ICSI

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07772375Not yet recruiting
Comparing two starting hormone doses for IVF in healthy younger women

This trial compares two starting doses of follicle-stimulating hormone (FSH) during in vitro fertilization (IVF) to see which works better. FSH helps your ovaries produce eggs, and the study aims to find the best dose for women with good fertility prospects.

Ho Chi Minh City, Ho Chi Minh City
NCT07323329Recruiting· Phase 2/Phase 3
Growth Hormone and DHEA for IVF in Women with Low Ovarian Reserve

This trial tests whether adding growth hormone and DHEA to your IVF medications can help women with low ovarian reserve get more eggs and improve pregnancy chances. It may be an option if you are over 40, have had few eggs before, or have low egg count markers.

Banī Suwayf, Beni Suweif Governorate
NCT06995261Recruiting
Follitropin delta in a long hormone-suppression IVF cycle

This trial tests a fertility drug called follitropin delta for women undergoing IVF. It checks if using this drug with a specific hormone-lowering protocol helps produce eggs for fertilisation.

Düsseldorf, North Rhine-Westphalia
NCT07216742Recruiting· Phase 3
Study of a fertility drug for women undergoing IVF with frozen embryo transfer

This trial tests a medication called human menopausal gonadotropin to help women undergoing IVF achieve a live birth. It focuses on the cumulative success rate after freezing and later transferring embryos.

Encino, California
NCT04719000Recruiting· Phase 4
Personalized LH addition during IVF to improve egg growth

This trial tests whether adding a personalized amount of “LH” during IVF hormone stimulation can help your ovaries respond better. It may be useful if you’ve had a weaker IVF response before and fit specific age and egg-quality markers.

Barcelona
NCT06883890Not yet recruiting· Phase 2
Extended LH for IVF patients with low LH

This trial tests whether giving extra LH hormone during an IVF cycle can improve outcomes for women who naturally have low LH levels. It may help your eggs develop better.

Hear when a new Infertility (IVF Patients) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.